Myasthenia gravis treatment with immunoglobulin injections

Myasthenia gravis is a life-threatening disease that often might lead to severe swallowing and breathing problems. This fact urges scientists and medical practitioners to create more therapy methods to decrease symptoms' severity and save patients' lives. One of the leading causes of myasthenia gravis symptoms is increased acetylcholine-related antibody production. So, doctors use drugs to decrease free antibodies in the patient's blood. They began to inject particular immunoglobulins (the other name for antibodies) into the bloodstream and achieved excellent results. The main idea of the treatment is related to the basics of how antibodies work. When the human organism detects a particular agent (part of the virus, some protein, etc. ), it begins to produce antibodies, and the immune system's primary goal is to fight this particular new threat. So, for some time, the organism slows down the production of other antibodies. Clinical trials show that injecting small dosages of short-term immunoglobulins IV helps to achieve better control rates of myasthenia gravis symptoms for a short period. Therefore, this method has proven to be a great way to help patients with acute swallow or breathing dysfunction-related life-threatening conditions.